Recall record at a glance
| Official record | F-1947-2019 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | EL Chilar Huff |
| Report date | Jul 31, 2019 |
| Recall initiation date | Jun 26, 2019 |
| Quantity | 1266 jars of lot E352; 1680 jars of lot E360; 384 (2 oz) jars of E360 i |
| Location | Apopka, FL, United States |
Official product description
Lisy Ground Cinnamon Canela Molida NET WT./CONT. NETO 13 OZ (368g) and 2 OZ (57g)
Why the product was recalled
Sample collected by NY Department of Agriculture tested positive for high levels of lead (2.39 ppm) in ground cinnamon.
Distribution information
Product sent to distributors in FL, NC, MD and NJ
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.